Literature DB >> 26610783

Treatment of Neuroendocrine Liver Metastases.

Heather A Farley1, Rodney F Pommier2.   

Abstract

Neuroendocrine tumors are rare and slow-growing malignancies that commonly metastasize to the liver, resulting hormonal syndromes and death from liver failure. Surgical consultation and liver debulking are key components in management. Traditional surgical resection guidelines do not apply to these tumors as with other cancers. Surgical resection has shown survival benefit even in the event of an incomplete resection. Ablation may be used as an adjunct to resection or in patients who are not candidates for resection. Asymptomatic patients with high-volume disease do as well with intra-arterial therapy as with surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Embolization; Liver; Metastasis; Neuroendocrine; Resection

Mesh:

Year:  2015        PMID: 26610783     DOI: 10.1016/j.soc.2015.08.010

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  15 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

2.  Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

Authors:  Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Yi Lv; Fabio Bagante; Luca Aldrighetti; George A Poultsides; Todd W Bauer; Ryan C Fields; Shishir Kumar Maithel; Hugo P Marques; Matthew Weiss; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-20       Impact factor: 3.452

3.  Oligometastases of Gastrointestinal Cancer Origin.

Authors:  Ernst Klar; Markus W Büchler; Hauke Lang; Florian Lordick; Jens Mittler; Takashi Mizuno; Guido Torzilli; Alexis Ulrich; Jean-Nicolas Vauthey
Journal:  Visc Med       Date:  2017-02-28

4.  Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases.

Authors:  Steven D Scoville; Dimitrios Xourafas; Aslam M Ejaz; Allan Tsung; Timothy Pawlik; Jordan M Cloyd
Journal:  World J Gastrointest Surg       Date:  2020-04-27

5.  Liver Transplantation for High-Grade Primary Hepatic Neuroendocrine Tumor with Diffuse Liver Metastasis.

Authors:  Saman Nikeghbalian; Ahad Eshraghian; Kourosh Kazemi; Alireza Shamsaeefar; Masood Hosseinzadeh; Bita Geramizadeh; Seyed Ali Malek-Hosseini
Journal:  J Gastrointest Cancer       Date:  2020-03

6.  The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.

Authors:  Jonathan G Sham; Aslam Ejaz; Michele M Gage; Fabio Bagante; Bradley N Reames; Shishir Maithel; George A Poultsides; Todd W Bauer; Ryan C Fields; Matthew J Weiss; Hugo Pinto Marques; Luca Aldrighetti; Timothy M Pawlik; Jin He
Journal:  J Gastrointest Surg       Date:  2018-07-06       Impact factor: 3.452

7.  Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.

Authors:  Gaya Spolverato; Fabio Bagante; Luca Aldrighetti; George Poultsides; Todd W Bauer; Ryan C Field; Hugo P Marques; Matthew Weiss; Shishir K Maithel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

8.  A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database.

Authors:  Andrea Ruzzenente; Fabio Bagante; Francesca Bertuzzo; Luca Aldrighetti; Giorgio Ercolani; Felice Giuliante; Alessandro Ferrero; Guido Torzilli; Gian Luca Grazi; Francesca Ratti; Alessandro Cucchetti; Agostino M De Rose; Nadia Russolillo; Matteo Cimino; Pasquale Perri; Ivana Cataldo; Aldo Scarpa; Alfredo Guglielmi; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2016-08-08       Impact factor: 3.452

9.  Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.

Authors:  William E Gibson; Raul S Gonzalez; Justin M M Cates; Eric Liu; Chanjuan Shi
Journal:  Hum Pathol       Date:  2018-05-12       Impact factor: 3.466

10.  Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.

Authors:  Samuel Jang; Haining Jin; Madhuchhanda Roy; Alice L Ma; Shaoqin Gong; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer Med       Date:  2017-08-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.